A multigenic approach to predict breast cancer risk

Breast Cancer Research and Treatment

Volumn 104, Issue 2, 2007, Pages 159-164

  Gerger, Armin ^a   Langsenlehner, Uwe ^a   Renner, Wilfried ^a   Weitzer, Werner ^a   Eder, Tanja ^a   Yazdani Biuki, Babak ^a   Hofmann, Günter ^a   Samonigg, Hellmut ^a   Krippl, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Breast cancer; Classification tree; Epidemiology; Multigenic; Polymorphisms

Indexed keywords

CYCLOOXYGENASE 2; INTERSTITIAL COLLAGENASE; STROMELYSIN; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CELL PROLIFERATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; EXTRACELLULAR MATRIX; FEMALE; FOLATE METABOLISM; GENETIC RISK; GENOTYPE; HUMAN; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT;

BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 34447526772     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9408-4     Document Type: Article

References (28)

1. Greenlee RT, Hill-Harmon MB, Murray T et al (2001) Cancer statistics. CA Cancer J Clin 51(1):15-36
2. Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 350(9084):1047-1059
3. Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 347(9017):1713-1727
4. Hulka BS, Stark AT (1995) Breast cancer: cause and prevention. Lancet 346(8979):883-887
5. Kelsey JL (1993) Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15(1):256-263
6. Potter J (1997) World cancer research fund-American institute of cancer research. Food, nutrition and the prevention of cancer: a global perspective. Banta Book Group, Mebasha, USA
7. Antoniou AC, Pharoah PD, McMullan G et al (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21(1):1-18
8. Rannala B (2001) Finding genes influencing susceptibility to comples diseases in the post-genome era. Am J Pharmacogenomics 1(3):203-221
9. Zhang H, Bonney G (2000) Use of classification trees for association studies. Genet Epidemiol 19(4):323-332
10. Popanda O, Schattenberg T, Phong CT et al (2004) Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25(12):2433-2441
11. Han J, Colditz GA, Samson LD et al (2004) Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res 64(9):3009-3013
12. Gu J, Zhao H, Dinney CP et al (2005) Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res 11(4):1408-1415
13. Cheng TC, Chen ST, Huang CS et al (2005) Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113(3):345-353
14. Esterbauer H, Schneitler C, Oberkofler H et al (2001) A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28(2):178-183
15. Langsenlehner U, Yazdani-Biuki B, Eder T et al (2006) The cyclooxygenase-2 (PTGS2) 8473T > C polymorphism is associated with breast cancer risk. Clin Cancer Res 12(4):1392-1394
16. Langsenlehner U, Renner W, Yazdani-Biuki B et al (2006) Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk. Breast Cancer Res Treat 97(1):67-72
17. Langsenlehner U, Krippl P, Renner W et al (2005) Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat 90(2):113-115
18. Krippl P, Langsenlehner U, Samonigg H et al (2004) Vascular endothelial growth factor in predicting outcome in breast cancer. Clin Cancer Res 10(24):8752-8753
19. Krippl P, Langsenlehner U, Renner W et al (2004) Re: Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst 96(19):1478-1479
20. Langsenlehner U, Krippl P, Renner W et al (2004) Genetic variants of the sulfotransferase 1A1 and breast cancer risk. Breast Cancer Res Treat 87(1):19-22
21. Krippl P, Langsenlehner U, Renner W et al (2004) The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Clin Cancer Res 10(10):3518-3520
22. Krippl P, Langsenlehner U, Renner W et al (2004) The 825C > T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer. Cancer Lett 206(1):59-62
23. Krippl P, Langsenlehner U, Renner W et al (2003) The 870G > A polymorphism of the cyclin D1 gene is not associated with breast cancer. Breast Cancer Res Treat 82(3):165-168
24. Krippl P, Langsenlehner U, Renner W et al (2003) The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk. Cancer Lett 201(2):181-184
25. Langsenlehner U, Krippl P, Renner W et al (2003) The common 677C > T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res Treat 81(2):169-172
26. Krippl P, Langsenlehner U, Renner W et al (2003) A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106(4):468-471
27. Breiman L, Friedman J (1984) Classification and regression trees. Pacific Grove, Wadsworth
28. Steinberg D, Colla P (1995) CART: tree-structured non-parametric data analysis. Salford Systems, San Diego